Doctor profile · Federal record
Dr. Mark Ray, M.D.
Dermatology Physician (CMS: Dermatology) · Carrollton, TX
- NPI 1720022874
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 40 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
4340 N Josey Ln, Suite 100
Carrollton, TX 750104602
(972) 492-7900
fax (972) 492-7583
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- June 4, 2013
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #H2710
- Medicaid
- TX #080611901
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720022874. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,877
Distinct HCPCS
10
Medicare allowed
$331,063
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,193 | 229 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 738 | 558 | $86 | |
17110 |
Destruction of skin growth, 1-14 growths | 653 | 501 | $107 | |
17000 |
Destruction of precancer skin growth, 1 growth | 454 | 326 | $40 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 348 | 220 | $120 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 309 | 23 | $1 | |
11102 |
Biopsy of related skin growth, first growth | 265 | 207 | $71 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 139 | 139 | $108 | |
11103 |
Biopsy of related skin growth, each additional growth | 86 | 54 | $48 | |
11642 |
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 61 | 55 | $131 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 146. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$963
Transactions
49
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $197.62 | |
| Arcutis Biotherapeutics, Inc. | 13 | $132.89 | |
| Janssen Biotech, Inc. | 4 | $117.97 | |
| ABBVIE INC. | 5 | $107.73 | |
| Incyte Corporation | 4 | $96.15 | |
| Amgen Inc. | 3 | $76.48 | |
| UCB, Inc. | 2 | $58.81 | |
| Novartis Pharmaceuticals Corporation | 1 | $31.49 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $23.84 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $23.67 | |
| Tempus AI, Inc | 1 | $23.28 | |
| GENZYME CORPORATION | 1 | $22.08 | |
| Galderma Laboratories, L.P. | 1 | $20.72 | |
| Lilly USA, LLC | 1 | $15.87 | |
| Almirall LLC | 1 | $13.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,386
Patients
860
Total drug cost
$78,880
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 375 | 279 | $3,622 |
| Hydrocortisone | Generic | 297 | 190 | $3,876 |
| Triamcinolone Acetonide | Generic | 184 | 119 | $2,902 |
| Ketoconazole | Generic | 183 | 94 | $2,670 |
| Clobetasol Propionate | Generic | 177 | 107 | $9,007 |
| Doxycycline Hyclate | Generic | 39 | 22 | $1,713 |
| Clindamycin Phosphate | Generic | 27 | 18 | $1,535 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 27 | 15 | $920 |
| Prednisone | Generic | 22 | 0 | $117 |
| Metronidazole | Generic | 21 | 16 | $1,184 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Ray's medical specialty?
Dr. Mark Ray practices Dermatology Physician in Carrollton, TX.
Where does Dr. Mark Ray practice?
Dr. Mark Ray practices at 4340 N Josey Ln, Carrollton, TX 750104602. Office phone: 9724927900.
What is Dr. Mark Ray's NPI?
Dr. Mark Ray's National Provider Identifier (NPI) is 1720022874, issued by NPPES.
Does Dr. Mark Ray accept Medicare assignment?
Yes. Dr. Mark Ray accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Ray commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.